Tech Company Financing Transactions
Kalm Therapeutics Funding Round
Private investors participated in a $700 thousand Seed funding round for Kalm Therapeutics. The round was announced on 8/14/2024.
Transaction Overview
Company Name
Announced On
8/14/2024
Transaction Type
Venture Equity
Amount
$700,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to complete regulatory activities outlined in its Pre-IND meeting with the FDA, fund vital personnel, and transfer the patch production to its manufacturer.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
6820 Moquin Drive NorthWest
Huntsville, AL 35806
USA
Huntsville, AL 35806
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
In 2022, Kalm Therapeutics was born out of a personal struggle. Founder and CTO AJ Singhal's six-year-old daughter, a budding swimmer, faced worsening eczema from participating in swim team. What began as a promising summer quickly turned into a nightmare as painful, itchy rashes flared up in the creases of her elbows, making it nearly impossible for her to enjoy the water she loved so much.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chis Seibert
Chief Marketing Officer
Tomoko Maeda-Chubachi
Chief Technical Officer
AJ Singhal
VP - Bus. Development
Tacey Viegas
Browse more venture capital transactions:
Prev: 8/14/2024: Chartis venture capital transaction
Next: 8/14/2024: EliseAI venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document all VC transactions involving tech companies. All VC database entries on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs